Member Info for MajorOak

CREO Medical US buyer in pre market trading again ?

After 11:30am GMT we have seen 4 weeks of big sells prior to 1:30pm GMT when the US opens.

Looking to see if we get a big late today early tomorrow ?

Again those trades up to 13:30 gmt.

Pre-market US and has been for the month.

£21k sale will be to fill a US order later in the day ... Again

Creo Medical late Friday trades £46,000 of the £53,000 35 minutes from end of weeks trading.

From my post 28th June. Will we see something like the above after LSE Close at 16:30pm ?

If so first thing on LSE could be quite nice.

I conservative suggestion towards October and above 20p. Pesonally I think by then it will superceed the 20p by a good healthy %

Creo Medical on the LSE had a batch of pre-market orders to fill , batches of buying up to 13:25 to fill request for shares stateside.

Once these have been processed and moved in to US Investors hands the US side will need more shares for their afternoon so I would hope to see a further clck up today.

Same pattern for tomorrow should offer up whether it is US buying or not.

Creo Medical up 5% on H1'25 Financial Update.

"Cash and cash equivalents at 30 June 2025 was £20.5m (31 December 2024: £8.7m)."

Looking very good for another £15m on top as H2 is normally more productive.

I suspect this is now the time that shareholders can actually see the operational side of Creo Medical hitting its targets and generating more revenue as the US gets up to speed AND EUROPE will begin to be mentioned with a much more proactive and tangible sign of a company being solid and moving forwards with new adoption technology.

Extremely happy with todays news.

Creo Medical positive news for commercial traction in the US, in June 2025, the Company announced FDA clearance for its SpydrBlade™ Flex device, a unique multi-modal endoscopic device designed for precision and adaptability in therapeutic endoscopy procedures and the latest product in Creo's GI suite of advanced energy products."

I have been saying for the last month that the sp here is being driven mainly when the buys occur from 11:30-3pm which is pre-market orders and live trading in the US.

Same today.

US Creo Medical data will DRIVE the profit from here as FDA clerances and actual revenue begins to start !

Watch this space in the USA.

"Recent developments in the US have provided positive support for the long-term roll-out of Creo's products. The two new Category I CPT reimbursement codes for upper gastrointestinal ("GI") and lower GI Endoscopic Submucosal Dissection procedures are expected to enable and encourage the use of next-generation products such as Speedboat® UltraSlim, and Speedboat® Notch, designed specifically for such procedures. The Board believes this financial incentive will encourage the US market to move from diagnostic procedures to therapeutic procedures in upper and lower GI."

Creo Medical Operating Costs Reduced by £5.2m v H1'24. Again GREAT to see revenues going up and costs coming down across the board.

"Underlying operating loss on a continuing basis has reduced to £6.9m (H1'24: £12.1m)."

Creo Medical cash and equivalents UP £12m approx in just H1'25.

"Cash and cash equivalents at 30 June 2025 was £20.5m (31 December 2024: £8.7m)."

Creo Medical 40% up in revenue for H1'25. Great to see the company hitting its targets.

"H1'25 Core Technology revenues from continuing operations were up 40% to £2.2m (H1'24: £1.6m), in line with management expectations for first half performance. The Board is pleased with current trading into the second half of the financial year and believes the Company is tracking on plan for 40% to 60% revenue growth for the full year, in-line with prior guidance, with a continued historical H2 weighting."

CREO MEDICAL - Watch the trades from 11:30am GMT for premarket buying in the US ?

Just been a big sell ready to fill a US order after 11:30 is my guess

Https://isrg.intuitive.com/news-releases/news-release-details/vessel-sealer-curved-receives-fda-clearance

Creo Medical's Vessel Sealer Curved is a surgical instrument designed for grasping, blunt dissection, bipolar coagulation, and mechanical transection of blood vessels and tissue bundles up to 7mm in diameter. It features a slim, curved jaw to improve visibility and control in tight spaces, and utilizes advanced bipolar radiofrequency energy ?

I am watching trading from now until 3pm to see 'if' this European update interests buying from the US.

Been very little volume so far. 11:30am

Great that CREO Medical are updating as they go.

Creo Medical Group PLC (AIM:CREO), the AIM-listed medical device company, has treated its first patient in a new clinical study testing its MicroBlate Flex device for lung tumour treatment.

The evaluation, running at Amsterdam University Medical Centre and London’s Royal Brompton Hospital, is designed to assess how well the MicroBlate Flex performs when used to ablate – destroy, in other words – lung tumours before surgical removal.

By analysing the tumour after surgery, doctors can compare the actual results to pre- and post-treatment scans, giving a clear picture of the device’s effectiveness.

This latest study adds to Creo’s ongoing clinical work, including another post-market trial focused on patient safety and long-term follow-up, as well as a partnership with Intuitive.

The latter involves robotically guided tumour ablation using MicroBlate Flex combined with Intuitive’s Ion system, aiming to build a strong clinical case before the device becomes widely available.

"Our collaboration with Intuitive further strengthens our emerging position at the forefront of minimally invasive lung cancer treatment and highlights the broad potential of MicroBlate Flex as we move toward commercialisation," said CEO Craig Gulliford.

CREO medical partner gets CE mark for European Operations.

"Da Vinci 5 is Intuitive’s most advanced and integrated multiport robotic-assisted surgical system, building on the da Vinci Xi Surgical System’s highly functional design.

It features more than 150 enhancements and joins a portfolio of da Vinci surgical systems that surgeons have used in more than 410,000 procedures in Europe in 2024 and nearly 17 million procedures worldwide to date.

“We are pleased that our da Vinci 5 Surgical System has received CE mark approval, marking its entry to Europe,” said Intuitive Chief Executive Officer Dave Rosa.

“At Intuitive, we’re focused on providing healthcare systems across Europe and around the world with thoughtful innovation that solves problems today and into the future. After over a decade of careful development, da Vinci 5 is the most advanced and integrated platform we’ve ever created – designed to enable better outcomes, efficiency, and insights for the future of minimally invasive care,” said Rosa."

CREO MEDICAL - Cancer treatment results look good.

It's terrific to see our Speedboat technology featured in new research presented at #BSGLive2025: Endoscopic management of low risk colorectal cancer – interim first results from registry and audit of speedboat-endoscopic submucosal dissection.”

🔎The paper concluded that: “Speedboat-Endoscopic Submucosal Dissection S-ESD has low rate of local recurrence and appears to provide organ preservation after local removal of early colorectal cancers.”

Read the full paper in GUT: https://lnkd.in/evM6yTsP or learn more about our #advancedenergy solutions for #thirdspaceendoscopy at https://lnkd.in/ebTRumEF

Creo Medical late Friday trades £46,000 of the £53,000 35 minutes from end of weeks trading.

US buying again ?

I feel NHS contracts will be forthcoming as trials progress. With Labour needing success on any possible nettle to grab, the pure cost saving per operation seem's to be a no brainer for UK business.

I'm sure the Health Security will know about Creo Medical and the US global heavyweight they partner with.

Again a good bargining chip when dealing with the likes of Trump the "saviour" of the world as we n the West think.

Chinese bohemoth Micro-tec will not want Intuitive Surgical to get all the good news either !

The expectations here need to be managed once the operation totals start to rise soon in the US.

Any NHS news on top should see Creo Medical reach the next plateau in sp.

CREO Medical - USA Medinol - Micro-tech get FDA Approved Micro heart moniter via endoscope, saving time and money.

https://medinol.com/news/microtech-announces-the-first-u-s-atrial-microsensor-implantations-as-part-of-its-fih-study/

"Medinol's subsidiary, Micro-Tech, has partnered with Creo Medical to leverage microwave technology in medical devices. Here's what we know about their licenses and partnership ¹ ² ³:

- *Partnership Details*: Micro-Tech acquired a 51% stake in Creo Medical S.L.U., a subsidiary of Creo Medical Group, for €72 million. This partnership enables Micro-Tech to expand its sales channels in Europe, while Creo Medical benefits from accessing Micro-Tech's product portfolio.

- *Microwave Technology*: Creo Medical's CROMA Advanced Energy Platform uses microwave energy for controlled coagulation and ablation of soft tissue. The platform features a 5.8 GHz super high frequency microwave energy system.

- *Licenses and Approvals*: While the documents don't explicitly mention US licenses for microwave technology, Creo Medical's devices, such as Speedboat Inject, have CE marks and are used in various countries. The partnership might facilitate approvals and licenses in the US, but specific details are not publicly available.

- *Device Applications*: Creo Medical's devices, like Speedboat Inject, are designed for therapeutic endoscopy and feature advanced bipolar radiofrequency and super high frequency microwave energy. These devices aim to provide precise cutting, coagulation, and ablation capabilities.

To determine the specifics of Medinol-owned Micro-Tech's licenses to use microwave technology in the US with Creo Medical devices, it's best to consult directly with the companies or check their official websites for updates on regulatory approvals."

Is this possibly Creo involvment?

USA FDA Approval announced 10-12 days ago so maybe the reason for the buying seen after 11:30am GMT as a US buyer builds a position ?

The charts imho show most recently a trend to mid session buying = premarket orders from the US ?